Join us as we reveal the content that made the greatest impact in 2024.
As we bid farewell to 2024, we reflect on an incredible year of content and extend a heartfelt thanks to our touchDERMATOLOGY community, including our leading experts and medical society partners, for their continued support in helping us deliver high-quality and easily accessible content. From expert Q&As and podcasts to conference highlights, news, and medical education, this year’s content has been created to inspire your practice and, ultimately, enhance patient care.
Here’s a look back at some of our standout moments from the year.
Most read article:
In this short piece, we sit down with Dr. Shari Lipner to uncover the inspirations behind her choice of specialty, the pivotal milestones in her career, the valuable lessons she has learned along the way, and her vision for the future of dermatology and the field of nail disorders.
Most watched video:
Dr. James Del Rosso shares insights into molluscum contagiosum, highlighting unmet treatment needs and exploring the role and effectiveness of the 0.7% cantharidin drug-device combination.
Most listened to podcast:
JAK inhibitors: A new player for hard-to-treat skin conditions 
Dr. Bill Damsky, MD, joins us to discuss the impact JAK inhibitors have on tackling a wide range of skin conditions. We explore their journey from proof-of-concept to becoming a treatment option for traditionally hard-to-treat and rare conditions, touch on the ongoing safety debate, and highlight their future impact.
Most viewed news story:
Semaglutide shows promise in treating hidradenitis suppurativa in patients with obesity
In this news article, we explore the recent study results presented at EADV, which demonstrate that the GLP-1 receptor agonist semaglutide could be a highly effective treatment for hidradenitis suppurativa—a condition where effective and well-tolerated treatment options remain limited.
